PSA Progression

Oncology

18 drugs in development·4 companies·2 clinical trials

Drug Pipeline by Phase

Phase 3(3)

Phase 2(12)

Drug	Company
Abiraterone Acetate	ENANTA PHARMACEUTICALS INC (ENTA)
Bicalutamide	ENANTA PHARMACEUTICALS INC (ENTA)
Bicalutamide	Janux Therapeutics, Inc. (JANX)
Degarelix	Royalty Pharma plc (RPRX)
Degarelix	Myovant Sciences Ltd. (MYOV)
Degarelix	Janux Therapeutics, Inc. (JANX)
Degarelix	ENANTA PHARMACEUTICALS INC (ENTA)
Flutamide	Janux Therapeutics, Inc. (JANX)
Flutamide	ENANTA PHARMACEUTICALS INC (ENTA)
Goserelin Acetate	Janux Therapeutics, Inc. (JANX)
Nilutamide	Janux Therapeutics, Inc. (JANX)
Nilutamide	ENANTA PHARMACEUTICALS INC (ENTA)

Phase 4(3)

BioSniper tracks 18 drugs in development for PSA Progression across 4 companies.

There are 2 clinical trials targeting PSA Progression tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.